Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers

Acta Pharmacologica Sinica

Volumn 26, Issue 5, 2005, Pages 527-532

  Wang, Li Yun ^a   Wang, Yun ^a   Zheng, Jian Quan ^a   Zhong, Bo Hua ^a   Liu, He ^a   Dong, Si Jian ^a   Ruan, Jin Xiu ^a   Liu, Ke Liang ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Muscarinic acetylcholinic receptors; Optical isomers; Pharmacological profiles; Radioligand binding assay

Indexed keywords

CARBACHOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR; OXOTREMORINE; PENTOBARBITAL; PHENCYNONATE; QUINUCLIDINYL BENZILATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ARTICLE; BRAIN CORTEX; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENANTIOMER; FEMALE; ISOMER; LIGAND BINDING; MALE; MOTION SICKNESS; NONHUMAN; RAT; RECEPTOR AFFINITY;

ANIMALS; AZA COMPOUNDS; BINDING, COMPETITIVE; CARBACHOL; CEREBRAL CORTEX; CHOLINERGIC ANTAGONISTS; FEMALE; GLYCOLATES; GUINEA PIGS; HYPNOTICS AND SEDATIVES; MALE; MICE; MUSCLE CONTRACTION; OXOTREMORINE; PENTOBARBITAL; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RATS; RECEPTORS, MUSCARINIC; SALIVATION; SLEEP; STEREOISOMERISM;

EID: 18744386986     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00089.x     Document Type: Article

References (17)

1. Ariens EJ, Wuis EW, Veringa EJ. Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology. Biochem Pharmacol 1988; 37: 9-18.
2. Birkett DJ. Racemates or enantiomers: regulatory approaches. Clin Exp Pharmacol Physiol 1989; 16: 479-83.
3. Ariens EJ. Stereochemistry: a source of problems in medicinal chemistry. Med Res Rev 1986; 6: 451-66.
4. Dai JG, Liu CG, Yu LS, Yang AZ, Jia HB, Wang KN. Antimotion sickness effect of phencynonate hydrochloride in man. Chin J Aerospace Med 1997; 8: 10-4.
5. Yamamura HI, Snyder SH. Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 1974; 71: 1725-9.
6. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
7. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48-58.
8. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099-108.
9. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998; 47: 395-406.
10. Kohl RL, Homick JL. Motion sickness: a modulatory role for the central cholinergic nervous system. Neurosci Biobehav Rev 1983; 7: 73-85.
11. Taillemite JP, Devaulx P, Bousquet F. Motion sickness. Med Trop 1997; 57: 483-7.
12. Deng YJ, Zhang YM. Study on the efficacy of phencynonate hydrochloride tablets in prevention of motion sickness. Chin J New Drugs 2001; 10: 453-4
13. Nakamura T, Matsui M, Uchida K, Futatsugi A. M (3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. J Physiol 2004; 558: 561-75.
14. Gautam D, Heard TS, Cui Y, Miller G, Miller G, Bloodworth L, Wess J. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice. Mol Pharmacol 2004; 66: 260-7
15. Ehlert FJ, Thomas EA. Functional role of M2 muscarinic receptors in the guinea pig ileum. Life Sci 1995; 56: 965-71.
16. Honda K, Takano Y, Kamiya H. Pharmacological profiles of muscarinic receptors in the longitudinal smooth muscle of guinea pig ileum. Jpn J Pharmacol 1993; 62: 43-7.
17. Volpicelli LA, Levey AI. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 2004; 145: 59-66.